Stocks
Vanda Pharmaceuticals (VNDA) ROE US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| ROE, % | ? | 6.57% | 1.19% | 0.46% | -3.51% | -67.4% | -85.3% | |
| Changes by years, y/y, % | +1pp | -5pp | -1pp | -4pp | -64pp | |||
Vanda Pharmaceuticals. ROE, %
Vanda Pharmaceuticals. ROE, changes, pp
Vanda Pharmaceuticals (VNDA) ROE US GAAP (quarter values) |
||||||||
| FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | FY2026Q2 | LTM ? | |||
| ROE, % | ? | -18.1% | -67.4% | -85.3% | -124.8% | -124.8% | -85.3% | |
| Changes by years, y/y, % | -15pp | -64pp | -77pp | -111pp | -111pp | |||
| Changes by quarters, q/q, % | -4pp | -49pp | -18pp | -40pp | 0pp | |||
